GREGORY POIRIER: Open Payments
NPI 1124100649 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,780 in 72 payments from 22 companies in 2025. Trend: 2023 $445 · 2024 $1,341 · 2025 $1,780
Food & beverage: $1,780
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 7 | $212 |
| Dendreon Pharmaceuticals LLC | 10 | $208 |
| PFIZER INC. | 6 | $155 |
| Janssen Biotech, Inc. | 6 | $148 |
| Sumitomo Pharma America, Inc. | 6 | $144 |
| ABBVIE INC. | 5 | $131 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $98 |
| IMMUNITYBIO, INC. | 4 | $88 |
| Endo USA, Inc. | 3 | $66 |
Products named: PROVENGE, XTANDI, ERLEADA, GEMTESA, PLUVICTO, YONSA, BOTOX, ANKTIVA.
Industry payments across MA — which companies pay providers there.
